Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal findings on angiography

Mayo Clinic Proceedings

Volumn 76, Issue 8, 2001, Pages 813-822

  Al Suwaidi, J ^a   Higano, S T ^a   Holmes D R , Jr ^a   Lerman, A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BLOOD FLOW; HUMAN; PATHOPHYSIOLOGY; THORAX PAIN;

EID: 0034899151     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)63226-6     Document Type: Article

References (102)

1. Unexplained chest pain: When is it panic disorder?
2. Selective cine coronary arteriography: Correlation with clinical findings in 1,000 patients
3. The anginal syndrome associated with normal coronary arteriograms: Report of a six year experience
4. Psychological morbidity in patients with chest pain and normal or near-normal coronary arteries: A long-term follow-up study
5. Psychosocial outcome and use of medical resources in patients with chest pain and normal or near-normal coronary arteries: A long-term follow-up study
6. Somatic and social prognosis of patients with angina pectoris and normal coronary arteriography: A follow-up study
7. The effect of noncritical coronary artery disease on long-term survival
8. Long-term follow-up of patients initially diagnosed with syndrome X
9. Unexplained chest pain in patients with normal coronary arteriograms: A follow-up study of functional status
10. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease
11. The anginal syndrome with normal coronary arteriography
12. Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms: Comparison with patients having significant coronary artery disease
13. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms
14. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries
15. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain
16. Pathophysiological dilemma of syndrome X
17. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms
18. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms
19. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects
20. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms
21. Endothelial dysfunction in patients with chest pain and normal coronary arteries
22. Angina caused by reduced vasodilator reserve of the small coronary arteries
23. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries
24. Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary arteriograms
25. Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms
26. Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms
27. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms
28. Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries
29. Endothelium-dependent dilation of the coronary arteries in syndrome X: Effects of the cold pressor test
30. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries
31. Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X
32. Hyperinsulinemia, coronary artery disease and syndrome X
33. Enhanced exercise-induced hyperkalemia in patients with syndrome X
34. Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men
35. Abnormal autonomic control of the cardiovascular system in syndrome X
36. Autonomic balance in patients with angina and a normal coronary angiogram
37. Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest
38. Impaired baroreflex sensitivity and sympathovagal balance in syndrome X
39. Enhanced red cell sodium-hydrogen exchange in microvascular angina
40. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: A potential link between cardiac and metabolic syndrome X
41. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation
42. 123I]metaiodobenzylguanidine myocardial scintigraphy
43. Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X
44. Abnormal cardiac pain perception in syndrome X
45. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries
46. Role of the central endogenous opiate system in patients with syndrome X
47. Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms
48. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X
49. Myocardial insulin resistance in patients with syndrome X
50. Inappropriate microvascular constriction produced transient ST-segment elevation in patients with syndrome X
51. Angina pectoris caused by coronary microvascular spasm
52. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
53. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress
54. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia
55. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans
56. Endothelial dysfunction: Does it matter? Is it reversible?
57. Reduction of coronary reserve: A mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries
58. Role of endothelial dysfunction and estrogens in syndrome X
59. Transmural differences in sympathetic coronary constriction during exercise in the presence of coronary stenosis
60. Control of coronary vasomotor tone in ischaemic myocardium by local metabolism and neurohumoral mechanisms
61. Alpha-adrenergic mechanisms in myocardial ischemia
62. Provocation of coronary artery spasm by the cold pressor test: Hemodynamic, arteriographic and quantitative angiographic observations
63. Adrenergically mediated coronary vasoconstriction in patients with syndrome X
64. Differential plasma endothelin levels in sub-groups of patients with angina and angiographically normal coronary arteries
65. Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X
66. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms
67. Syndrome X
68. Microvascular angina in patients with normal coronary arteries and with other ischaemic syndromes
69. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease
70. Comparison of coronary endothelial dynamics with electrocardiographic and left ventricular contractile responses to stress in the absence of coronary artery disease
71. Acute effects of nitrates on exercise testing in patients with syndrome X: Clinical and pathophysiological implications
72. The paradox of nitrates in patients with angina pectoris and angiographically normal coronary arteries
73. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X
74. Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries: Effect of β adrenergic blockade
75. Comparison of verapamil versus propranolol therapy in syndrome X
76. Verapamil versus acebutolol for syndrome X
77. Efficacy of calcium channel blocker therapy for angina pectoris from small-vessel coronary artery disease and abnormal vasodilator reserve
78. Beneficial and detrimental effects of lidoflazine in microvascular angina
79. Acute coronary vasomotor effects of nifedipine and therapeutic correlates in Syndrome X
80. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina
81. Therapeutic benefits of cilazapril in patients with syndrome X
82. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms
83. Imipramine in patients with chest pain despite normal coronary angiograms
84. Improved exercise capacity with acute aminophylline administration in patients with syndrome X
85. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X)
86. Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X
87. 17-Beta-estradiol therapy lessens angina in postmenopausal women with syndrome X
88. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms
89. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X
90. The effect of transcutaneous electrical nerve stimulation on coronary and systemic haemodynamics in syndrome X
91. Long-term outcome of spinal cord electrical stimulation in patients with refractory chest pain
92. Spinal electrical stimulation for intractable angina - Long-term clinical outcome and safety
93. Spinal cord stimulation as a pain treatment for angina pectoris
94. Spinal cord stimulation in angina pectoris with normal coronary arteriograms
95. Chest pain with angiographically insignificant coronary arterial obstruction: Clinical presentation and long-term follow-up
96. Long-term prognosis of patients with angina like chest pain and normal coronary angiographic findings
97. Clinical characteristics and follow-up of patients with chest pain and normal coronary arteries
98. Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X")
99. Clinical morbidities in subjects with Doppler-evaluated endothelial dysfunction of coronary artery
100. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
101. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
102. Systemic amyloidosis presenting with angina pectoris